Dr. Payal D. Shah

Dermatology
D-H Dermatology
18 Old Etna Rd, 
Lebanon, NH 
Accepting New Patients
Referral may be required
Before you request
D-H Dermatology
18 Old Etna Rd, 
Lebanon, NH 

Overview

Payal Shah is a Dermatologist practicing medicine in Lebanon, New Hampshire.

Her clinical expertise encompasses Melanoma, PIK3CA-Related Overgrowth Spectrum, Febrile Neutropenia, Vitrectomy, and Penectomy.

She is actively involved in clinical research, co-authoring 151 peer reviewed articles and participating in 4 clinical trials. Dr. Shah is currently accepting new patients.

Specialties

Dermatology

Licenses

Dermatology in CT

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
BMC HealthNet
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
Cigna
  • EPO
  • HMO
  • PPO
Community Health Options
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health New England
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Martin's Point Generations
  • MEDICARE MAPD
  • OTHER MEDICARE
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
MVP Health
  • EPO
  • PPO
NH Healthy Families
  • EPO
  • MANAGED MEDICAID PLAN
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 14 Less Insurance Carriers -

Locations

D-H Dermatology
18 Old Etna Rd, Lebanon, NH 03766

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Randomized Phase III Post-operative Trial of Platinum Based Chemotherapy vs. Capecitabine in Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
A Randomized Phase III Post-operative Trial of Platinum Based Chemotherapy vs. Capecitabine in Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
Enrollment Status: Active_not_recruiting
Publish Date: July 27, 2026
Intervention Type: Drug
Study Drugs: Capecitabine, Carboplatin, Cisplatin
Study Phase: Phase 3
Harnessing Olaparib, Palbociclib and Endocrine Therapy: A Phase I/II Trial of Olaparib, Palbociclib and Fulvestrant in Patients With BRCA Mutation-associated, Hormone Receptor-positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Metastatic Breast Cancer (HOPE)
Harnessing Olaparib, Palbociclib and Endocrine Therapy: A Phase I/II Trial of Olaparib, Palbociclib and Fulvestrant in Patients With BRCA Mutation-associated, Hormone Receptor-positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Metastatic Breast Cancer (HOPE)
Enrollment Status: Completed
Publish Date: January 09, 2026
Intervention Type: Drug
Study Drugs: Palbociclib, Olaparib, Fulvestrant
Study Phase: Phase 1
A Phase 2 Study of Olaparib Monotherapy in Metastatic Breast Cancer Patients With Germline or Somatic Mutations in DNA Repair Genes (Olaparib Expanded)
A Phase 2 Study of Olaparib Monotherapy in Metastatic Breast Cancer Patients With Germline or Somatic Mutations in DNA Repair Genes (Olaparib Expanded)
Enrollment Status: Active_not_recruiting
Publish Date: January 05, 2026
Intervention Type: Drug
Study Drug: Olaparib
Study Phase: Phase 2
A Phase II Trial of Atezolizumab (Anti-PDL1) With Carboplatin in Patients With Metastatic Triple Negative Breast Cancer
A Phase II Trial of Atezolizumab (Anti-PDL1) With Carboplatin in Patients With Metastatic Triple Negative Breast Cancer
Enrollment Status: Completed
Publish Date: December 12, 2024
Intervention Type: Other, Drug
Study Drugs: atezolizumab, carboplatin
Study Phase: Phase 2
View 3 Less Clinical Trials

151 Total Publications

Breast Cancer Risk Assessment Has a Data Integration Problem: Can Artificial Intelligence Solve It?
Breast Cancer Risk Assessment Has a Data Integration Problem: Can Artificial Intelligence Solve It?
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: September 04, 2026
Similar Doctors
Expertise in
25
conditions
Dr. Joi B. Carter
Dermatology
Expertise in
25
conditions
Dr. Joi B. Carter
Dermatology
Referral may be required
Before you request

D-H Dermatology

18 Old Etna Rd, 
Lebanon, NH 
 (0.1 miles away)
603-650-3100
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Joi Carter is a Dermatologist practicing medicine in Lebanon, New Hampshire. Dr. Carter is highly rated in 25 conditions, according to our data. Her clinical expertise encompasses Mycosis Fungoides, Cutaneous T-Cell Lymphoma (CTCL), Basal Cell Skin Cancer, and Pyoderma Gangrenosum. Dr. Carter is currently accepting new patients.

Expertise in
26
conditions
Expertise in
26
conditions
Referral may be required
Before you request

D-H Dermatology

18 Old Etna Rd, 
Lebanon, NH 
 (0.1 miles away)
603-650-5000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Michael Chapman is a Dermatologist practicing medicine in Lebanon, New Hampshire. Dr. Chapman is highly rated in 26 conditions, according to our data. His clinical expertise encompasses Actinic Keratosis, Squamous Cell Skin Carcinoma, Melanoma, Pyoderma Gangrenosum, and Penectomy. Dr. Chapman is currently accepting new patients.

Expertise in
54
conditions
Expertise in
54
conditions
Referral required
Before you request

Mary Hitchcock Memorial Hospital

1 Medical Center Dr, 
Lebanon, NH 
 (2.1 miles away)
603-650-5000
Languages Spoken:
English, Mandarin
See accepted insurances
Accepting New Patients
Offers Telehealth

Carsten Hamann is a Dermatologist practicing medicine in Lebanon, New Hampshire. Dr. Hamann is highly rated in 54 conditions, according to our data. His clinical expertise encompasses Contact Dermatitis, Actinic Keratosis, Kaposiform Hemangioendothelioma, and Fetal Cystic Hygroma. Dr. Hamann is currently accepting new patients.

Frequently Asked Questions about Dr. Payal D. Shah

How do I make an appointment with Dr. Payal D. Shah?

You can book an appointment with Dr. Payal D. Shah by calling their office at 603-650-3100. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Payal D. Shah a top-rated expert for Vitrectomy?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Payal D. Shah is classified as an Experienced expert for Vitrectomy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Payal D. Shah specialize in?

While Dr. Payal D. Shah is a Dermatology, they have specific expertise in Vitrectomy, Melanoma, and PIK3CA-Related Overgrowth Spectrum. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Dermatology.

Does Dr. Payal D. Shah participate in research or clinical trials?

Yes. Dr. Payal D. Shah has published 151 articles and abstracts on conditions like Vitrectomy. You can view a list of Dr. Payal D. Shah's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Payal D. Shah accept my insurance?

Dr. Payal D. Shah accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 603-650-3100 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Shah's expertise for a condition
ConditionClose
        View All 21 Experienced Conditions
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile